20 filings
6-K
RGC
Regencell Bioscience Holdings Ltd
2 Jan 24
Report of Foreign Private Issuer
6:04am
6-K
RGC
Regencell Bioscience Holdings Ltd
15 Dec 23
Form of Letter of Lock-up Undertaking
6:09am
6-K
RGC
Regencell Bioscience Holdings Ltd
15 Jun 23
Regencell Bioscience Holdings Limited Announces First Half 2023 Management Financial Results
4:01pm
6-K
RGC
Regencell Bioscience Holdings Ltd
5 Jun 23
SECOND EXTENSION OF letter of Lock-Up Undertaking
6:04am
6-K
RGC
Regencell Bioscience Holdings Ltd
17 Mar 23
Report of Foreign Private Issuer
6:03am
6-K
i5200km uq4mee
28 Feb 23
Report of Foreign Private Issuer
9:15am
6-K
827wuny yme9trymuai0
4 Jan 23
Report of Foreign Private Issuer
8:00am
6-K
0or00ggvguu
22 Dec 22
Report of Foreign Private Issuer
7:00am
6-K
pg1l1sm99z wq8o8g6
12 Sep 22
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial
9:17am
6-K
ycid7s88wqc5pmes
2 Jun 22
Regencell Bioscience Holdings Limited Announces First Half 2022 Management Financial Results
4:16pm
6-K
3qfp6rxemz10ve1uni
18 May 22
Results of EARTH efficacy trial
7:57am
6-K
dhuukzhqz
16 May 22
Form of Letter of Lock-up Undertaking
6:23am
6-K
uetzs kdsiez487wkl
26 Apr 22
Report of Foreign Private Issuer
8:07am
6-K
6b3ui851
16 Feb 22
Report of Foreign Private Issuer
4:30pm
6-K
y3600 f3l1x
13 Dec 21
Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors
8:30am
6-K
v01hzc0udf8rp
17 Nov 21
Current report (foreign)
5:00pm
6-K
ehg vbc7sunqmsfz
7 Sep 21
Joint Venture Agreement
4:05pm
6-K
1hivkdowgjv8rh0752n9
1 Sep 21
Current Report of Private Issuer
4:20pm
6-K
lzmr0okjnvua 8okni
20 Aug 21
Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option
4:05pm
6-K
7hs3eg2
20 Jul 21
Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering
5:10pm
- Prev
- 1
- Next